SCHEMBL6837620

SCHEMBL6837620

CNCc1ccc(OC)c2oc(C(=O)NCc3ccccc3)cc12

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.53
HTT P42858 5/20 0.53
HSD17B10 Q99714 3/20 0.53
NPSR1 Q6W5P4 3/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
TSHR P16473 1/20 0.53
MAPK1 P28482 1/20 0.53
LMNA P02545 5/20 0.49
L3MBTL1 Q9Y468 3/20 0.49
HPGD P15428 7/20 0.49
TP53 P04637 2/20 0.49
GLA P06280 1/20 0.49
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 1/20 0.47
ADRA2A P08913 2/20 0.47
ADRA2B P18089 2/20 0.47
ADRA2C P18825 2/20 0.47
POLB P06746 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6837691 0.91 HTT (0.53) SMN1; SMN2HTTHSD17B10NPSR1MEN1
SCHEMBL6836758 0.90 NPC1 (0.53) SMN1; SMN2HTTHSD17B10NPSR1MEN1
SCHEMBL6833132 0.89 HTT (0.52) SMN1; SMN2HTTHSD17B10NPSR1MEN1
SCHEMBL6837509 0.88 HTT (0.51) SMN1; SMN2HTTHSD17B10NPSR1MEN1
SCHEMBL6836660 0.87 HTT (0.50) SMN1; SMN2HTTHSD17B10NPSR1MEN1
SCHEMBL6833260 0.87 PDE4A (0.49) SMN1; SMN2HTTHSD17B10NPSR1MEN1
SCHEMBL6833415 0.86 ADRA2A (0.54) SMN1; SMN2HTTHSD17B10NPSR1MEN1
SCHEMBL6833183 0.86 HTT (0.49) SMN1; SMN2HTTHSD17B10NPSR1MEN1
SCHEMBL6839181 0.86 ADRA2A (0.56) SMN1; SMN2HTTHSD17B10NPSR1MEN1
SCHEMBL6837763 0.86 HTT (0.49) SMN1; SMN2HTTHSD17B10NPSR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716987-B1 PHOSPHODIESTERASE IV INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-04-06 US disclosed
US-6514996-B2 Derivatives of benzofuran or benzodioxole KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-02-04 US disclosed
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE CBR1, CBR3, CYC1 SMN1; SMN2 1477/4885HTT 2698/4885HSD17B10 153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.